Obagi Medical Products, Inc. (OMPI) [Rocket]

Overview

Obagi Medical Products, Inc. (OMPI)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
05/13/2013	SC 13D/A	GAMCO INVESTORS, INC. ET AL reports a 0% stake in Obagi Medical Products, Inc.
05/10/2013	SC 13G/A	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
05/06/2013	15-12B	Form 15-12B - Securities registration termination [Section 12(b)]
04/29/2013	4	Leslie Kristina M (Director) has filed a Form 4 on Obagi Medical Products, Inc.
04/29/2013	4	Form 4 - Statement of changes in beneficial ownership of securities
04/29/2013	4	FITZGIBBONS ALBERT J III (Director) has filed a Form 4 on Obagi Medical Products, Inc.
04/29/2013	4	DUERDEN JOHN H (Director) has filed a Form 4 on Obagi Medical Products, Inc.

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-12	Dec-31-11	Dec-31-10	Dec-31-09	Dec-31-08	Dec-31-07	Dec-31-06	Dec-31-05
Revenues	120.7	114.1	112.8	104.1	104.6	102.6	78.0	64.9
Revenue growth	5.8%	1.2%	8.3%	-0.5%	1.9%	31.6%	20.1%	15.4%
Cost of goods sold	25.0	24.0	23.7	22.0	19.9	18.0	13.5	11.6
Gross profit	95.6	90.1	89.1	82.1	84.7	84.6	64.5	53.4
Gross margin	79.2%	78.9%	79.0%	78.8%	80.9%	82.4%	82.7%	82.2%
Selling, general and administrative	66.0	71.9	69.4	59.2	59.4	51.4	40.9	29.0
Research and development	2.2	2.2	3.9	4.4	5.3	5.5	5.9	3.3
EBITA	28.0	16.7	16.6	18.4	20.0	27.7	17.7	21.1
EBITA margin	23.2%	14.6%	14.7%	17.7%	19.1%	27.0%	22.8%	32.5%
Amortization of intangibles	0.6	0.6	0.7
EBIT	27.4	16.0	15.8	18.4	20.0	27.7	17.7	21.1
EBIT margin	22.7%	14.0%	14.0%	17.7%	19.1%	27.0%	22.8%	32.5%
Pre-tax income	27.4	15.9	15.8	18.5	20.1	25.5	9.6	15.0
Income taxes	10.8	5.9	6.3	7.1	7.5	10.3	3.5	6.0
Tax rate	39.3%	37.0%	40.1%	38.7%	37.4%	40.3%	36.1%	40.3%
Net income	16.6	10.0	9.5	11.3	12.6	15.2	6.1	0.0
Net margin	13.8%	8.8%	8.4%	10.9%	12.0%	14.8%	7.8%	0.0%

Diluted EPS	$0.90	$0.54	$0.44	$0.51	$0.56	$0.69	$0.34	$0.50
Shares outstanding (diluted)	18.5	18.7	21.8	22.0	22.6	22.1	18.1	0.0

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.